Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
57
-
Total 13F shares, excl. options
-
34.6M
-
Shares change
-
+1.39M
-
Total reported value, excl. options
-
$423M
-
Value change
-
+$16.8M
-
Number of buys
-
36
-
Number of sells
-
-14
-
Price
-
$12.23
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q2 2022
60 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.6M shares
of 73M outstanding shares and own 47.39% of the company stock.
Largest 10 shareholders include venBio Partners LLC (5.01M shares), Third Point LLC (4.31M shares), CITADEL ADVISORS LLC (3.89M shares), Logos Global Management LP (2.31M shares), Vivo Capital, LLC (1.92M shares), JANUS HENDERSON GROUP PLC (1.91M shares), FMR LLC (1.58M shares), RTW INVESTMENTS, LP (1.55M shares), EcoR1 Capital, LLC (1.3M shares), and ORBIMED ADVISORS LLC (1.29M shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.